−£339k
−416%vs Mar 2024Active08064938Private limited companyNottingham
BIOPHARMA STABILITY TESTING LABORATORY LIMITED
Significant control: Michael Charles Allwood (25–50%), Alan Shaun Wilkinson (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Biopharma Stability Testing Laboratory Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Biopharma Stability Testing Laboratory Limited sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BIOPHARMA STABILITY TESTING LABORATORY LIMITED is an active private limited company (company number 08064938) incorporated on 11 May 2012, registered in Nottingham. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 28 March 2025, showing net assets of −£339k and cash of £0, with 7 employees on average. Net assets fell 416% on the prior period (£107k).
Peer position · net assets
By net assets it sits in the bottom quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).
02
Ownership and control
- Dr Michael Charles Allwood
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Alan Shaun Wilkinson
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 11 May 201214 yrs ago
- Next accounts due
- 28 December 2026in 65 days
- Confirmation statement due
- 25 May 2027in 213 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£0
vs Mar 2024Not reported
7
+17%vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 March 2025 | −£339k | £0 | £12k | £275k | — | — | 7 |
| 28 March 2024 | £107k | £0 | £157k | £289k | — | — | 6 |
Current ratio0.04Current assets ÷ creditors within one year
Cash per employee£0Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-338,571 at 28 March 2025
- Net assets down 25% or more on the prior period-416.3% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.04
- Incorporated five or more years agoIncorporated 11 May 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 213 days
- Next accounts duein 65 days
- Accounts period endNet liabilities £339k · small accounts
- Accounts period endNet assets £107k · small accounts
- Incorporated
08
Similar companies in Nottingham
- M V LOCUMS LIMITEDNottingham · inc. Dec 2011
- HIPRA UK AND IRELAND LIMITEDNottingham · inc. Jul 2010
- NUVISION BIOTHERAPIES LIMITEDNottingham · inc. Apr 2015
- GREEN-VALIDATION-SERVICES- LTDNottingham · inc. May 2018
- BCM LIMITEDNottingham · inc. Aug 1992
All companies incorporated on 11 May 2012 · in May 2012.
09
Reminders for BIOPHARMA STABILITY TESTING LABORATORY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.